Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:IMRA

IMARA (IMRA) Stock Price, News & Analysis

IMARA logo

About IMARA Stock (NASDAQ:IMRA)

Advanced Chart

Key Stats

Today's Range
$37.88
$40.00
50-Day Range
$6.32
$25.28
52-Week Range
$0.97
$6.32
Volume
7,723 shs
Average Volume
138,364 shs
Market Capitalization
$1.01 billion
P/E Ratio
768.95
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IMRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IMARA and its competitors with MarketBeat's FREE daily newsletter.

IMRA Stock News Headlines

This Crypto Is Set to Explode in January
Billions Flowing Into Crypto (Here’s Where It’s Going!) Institutional money is flooding into crypto... Discover which coins they’re buying at the Crypto Hedge Fund Summit, before prices catch up.
Imara Blume
Imara Announces Stockholder Approval of Merger With Enliven
See More Headlines

IMRA Stock Analysis - Frequently Asked Questions

IMARA Inc. (NASDAQ:IMRA) issued its earnings results on Tuesday, November, 9th. The company reported ($2.20) earnings per share (EPS) for the quarter, topping the consensus estimate of ($3.64) by $1.44.

Shares of IMARA reverse split before market open on Friday, February 24th 2023.The 1-4 reverse split was announced on Friday, February 24th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, February 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

IMARA (IMRA) raised $76 million in an IPO on Thursday, March 12th 2020. The company issued 4,500,000 shares at a price of $16.00-$18.00 per share. Morgan Stanley, Citigroup and SVB Leerink served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that IMARA investors own include NIO (NIO), Novavax (NVAX), NVIDIA (NVDA), Axsome Therapeutics (AXSM), Alibaba Group (BABA), AMC Entertainment (AMC) and BioXcel Therapeutics (BTAI).

Company Calendar

Last Earnings
11/09/2021
Today
8/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:IMRA
CIK
1672619
Phone
N/A
Fax
N/A
Employees
41
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.05
Trailing P/E Ratio
768.95
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$1.49 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
2.12%
Return on Assets
2.00%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
48.98
Quick Ratio
48.98

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$0.51 per share
Price / Cash Flow
75.24
Book Value
$3.44 per share
Price / Book
11.17

Miscellaneous

Outstanding Shares
26,234,000
Free Float
16,449,000
Market Cap
$1.01 billion
Optionable
Not Optionable
Beta
1.09

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:IMRA) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners